Key result
Transfection of vascular smooth muscle cells with antisense MLCK mRNA abolished chemotaxic motility and lamellipodia formation in response to platelet-derived growth factor-BB.
Myosin light chain kinase (MLCK) is essential for chemotaxic motility and lamellipodia development in vascular smooth muscle cells.
MLCK inhibition may curb VSMC migration in vascular disease; leaves open in vivo and clinical translation.
We constructed a plasmid vector having a 1.4-kilobase pair insert of myosin light chain kinase (MLCK) cDNA in an antisense direction to express antisense mRNA. The construct was then transfected to SM3, a cell line from vascular smooth muscle cells, producing a few stable transfectants. The down-regulation of MLCK expression in the transfectants was confirmed by both Northern and Western blots. The control SM3 showed chemotaxic motility to platelet-derived growth factor-BB, which was supported by lamellipodia. However, the transfectants showed neither chemotaxic motility nor developed lamellipodia, indicating the essential role of MLCK in the motility. The specificity for the targeting was assessed by a few tests including the rescue experiment. Despite this importance of MLCK, platelet-derived growth factor-BB failed to induce MLC20 phosphorylation in not only the transfectants but also in SM3. The mode in which MLCK was involved in the development of membrane ruffling is discussed with special reference to the novel property of MLCK that stimulates the ATPase activity of smooth muscle myosin without phosphorylating its light chain (Ye, L.-H., Kishi, H., Nakamura, A., Okagaki, T., Tanaka, T., Oiwa, K., and Kohama, K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 6666-6671).
No takes yet. Share an insight, caveat, or question.
Kishi et al. (2000) studied this question. Antisense MLCK mRNA transfection vs. Control SM3 cells was evaluated on Chemotaxic motility and lamellipodia formation. Transfection of vascular smooth muscle cells with antisense MLCK mRNA abolished chemotaxic motility and lamellipodia formation in response to platelet-derived growth factor-BB.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: